The objective of the envisaged project is to validate the market concerning the provision of an integrated service aimed at monitoring patient compliance to therapy. The tests and validation of such a service will take place in a wide geographical area in Europe, namely Greece, Spain and UK, to assess the validity of chosen market approach for developing strategies for the wide geographical expansion intended. The service is not considered in the context of a mere market-oriented activity but as a research-based evolution that will be forwarded to the market in secure conditions and incorporated in the existing health care system. 